Schering in talks over Mitsui division purchase:
This article was originally published in Clinica
Executive Summary
Schering has confirmed it is in negotiations with Mitsui over the possible sale of the Japanese company's pharmaceutical division, which includes some X-ray contrast media. The German company would give no further details, but local Japanese press reports indicate that a contract could be signed as early as this month. The division would be integrated into Schering's Japanese unit, Nihon Schering KK, the press report says. Schering recently announced plans to buy US company Diatide and a major stake in ORIS/CIS Bio International of France.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.